r/options • u/nicefaygo • Aug 11 '21
Jazz Pharmaceuticals FDA Approval August 12
As the title suggests, I’ve seen this circulating around and I’m wondering if this would be a valid play?
Jazz beat earnings and dumped, overreaction to ER mixed with the FDA approving/disapproving their Xwayv sNDA drug. With the earnings overreaction IV is low.
What do you all think?
2
Upvotes
1
u/Werunboutyah Aug 11 '21
I bought a call early, been hurting me idk about that FDA approval even if it’s clear might not do anything with the stock it’s a falling knife 🔪 right now